Associate Professor of Law
B.S., summa cum laude, highest departmental honors, college honors, Integrative Medical Theory, 2005, University of California, Los Angeles; M.T.O.M., summa cum laude, 2005, Emperor's College; M.D., 2011, University of California, San Diego School of Medicine; J.D., 2011, Yale Law School; Phi Beta Kappa; Member, California and New York State Bars
Phone: (213) 738-8241
Ryan Abbott, M.D., J.D., M.T.O.M., is Associate Professor of Law at Southwestern Law School and Adjunct Assistant Professor of Medicine at the David Geffen School of Medicine at UCLA. He has served as a consultant on health care financing and regulation, intellectual property, and public health for international organizations, academic institutions and private enterprises including the World Health Organization and World Intellectual Property Organization. Professor Abbott has published widely on issues associated with health care law and intellectual property protection in legal, medical, and scientific peer-reviewed journals.
"As someone with a background in both law and medicine, I hope to provide students with a multidisciplinary approach to considering the complex issues they will face as attorneys. This will help students to consider client issues from a variety of perspectives."
Professor Abbott is a licensed and board certified physician, attorney, and acupuncturist. He is a graduate of the University of California, San Diego School of Medicine and the Yale Law School, as well as a Summa Cum Laude graduate from Emperor's College (MTOM) and a Summa Cum Laude graduate from University of California, Los Angeles (BS). Professor Abbott has been the recipient of numerous research fellowships, scholarships and awards, and has served as Principal Investigator of biomedical research studies at University of California. He is a registered patent attorney with the U.S. Patent and Trademark Office and a member of the California and New York State Bars.
Professor Abbott enjoys sharing his experience with his students. "As someone with a background in both law and medicine, I hope to provide students with a multidisciplinary approach to considering the complex issues they will face as attorneys," Professor Abbott explains. "This will help students to consider client issues from a variety of perspectives. Health care law is an important subject for lawyers; health care spending now makes up more than 18 percent of GDP, and a growing number of attorneys are finding health care related employment."
Professor Abbott has published widely on issues associated with health care law and intellectual property protection in legal, medical and scientific peer-reviewed journals. His primary focus is in writing traditional law-oriented scholarship at the intersection of health law and intellectual property. Professor Abbott's recent work, including law review articles in the Duke Law Journal and the Iowa Law Review, has focused on the Food and Drug Administration (FDA) and how the agency could utilize informational regulation and market-based mechanisms to better manage off-label and post-market drug use.
He is currently researching topics including: the challenges big data and artificial intelligence pose to patent law; the role of comparative effectiveness research in drug regulation; and the intellectual property implications of innovations related to human biological processes.
Books and Chapters
DOCUMENTING TRADITIONAL MEDICAL KNOWLEDGE (World Intellectual Property Organization, 2014)
REGIONAL ASSESSMENT OF PATENT AND RELATED ISSUES AND ACCESS TO MEDICINES, Volume I (with W. Bannenberg; CARICOM (Caribbean Community) Member States and the Dominican Republic, 2009)
REGIONAL ASSESSMENT OF PATENT AND RELATED ISSUES AND ACCESS TO MEDICINES, Volume II - Country Studies (with F. Abbott, W. Bannenberg and M. Schürmann; CARICOM (Caribbean Community) Member States and the Dominican Republic, 2009)
Hal the Innovator: Computational Invention and Its Patentability Implications in BIG DATA IS NOT A MONOLITH (H. Ekbia, et al., eds., MIT Press, forthcoming)
The Sentinel Initiative as a Cultural Commons in MEDICAL KNOWLEDGE COMMONS AND USER INNOVATION (Cambridge University Press, forthcoming)
The Use of Tai Chi and Qi Gong for Treatment and Prevention of Mental Disorders in INTEGRATIVE PSYCHIATRY (P. Muskin, P. Gerbarg, and R. Brown, eds., Psychiatr Clin North Am., March 2013)
Complementary and Alternative Medicine in CHILD AND ADOLESCENT PSYCHIATRY: LEGAL CONSIDERATIONS (Child Adolesc Psychiatr Clin Am., July 2013)
The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis, JOURNAL OF PSYCHOACTIVE DRUGS ( with D. Smith; 2015)
Effect of Perineal Self-Acupressure on Constipation: A Randomized Controlled Trial, JOURNAL OF GENERAL INTERNAL MEDICINE (with I. Ayres, E. Hui, and K. Hui; April 2015)
Can Bayesian Extrapolation Improve FDA Regulation of Off-Label Uses of Drugs and Devices?, FOOD AND DRUG LAW INSTITUTE'S FOOD AND DRUG POLICY FORUM (with I. Ayres; 2014)
FDA Involvement in Off-Label Use: Debate Between Richard Epstein and Ryan Abbott, 44 SOUTHWESTERN LAW REVIEW 1 (with R. Epstein; 2014)
Jordanian Stakeholder Attitudes Toward Generic Substitution, JOURNAL OF GENERIC MEDICINE (with Alabbadi, Ibrahim, and D. Jaber; June 2014)
Redefining Medical Necessity: A Consumer-Driven Solution to the U.S. Health Care Crisis, 47 LOYOLA OF LOS ANGELES LAW REVIEW 943 (with C. Stevens; 2014)
Post-Market Drug Regulation in the Age of Big Data: What Path to the Promised Land?, FOOD & DRUG L. POLICY FORUM (October 2014)
Evidence and Extrapolation: Mechanisms for Regulating Off-Label Uses of Drugs and Devices, DUKE LAW JOURNAL (with I. Ayres; forthcoming 2014)
Big Data and Pharmacovigilance: Using Health Information Exchanges to Revolutionize Drug Safety, 99 IOWA LAW REVIEW 225 (2013)
The Use of Tai Chi and Qi gong for the Treatment and Prevention of Mental Disorders, 36 PSYCHIATRIC CLINICS OF NORTH AMERICA 109 (Complementary and Integrative Therapies for Psychiatric Disorders Issue, P. Muskin, P. Gerbarg and P. Brown, eds.; with H. Lavaretsky; December 2013)
Medico-Legal Issues in Cardiology, 21 CARDIOL REVIEW 222 (with M. Cohen; Sep-Oct 2013)
Complementary and alternative medicine in child and adolescent psychiatry: legal considerations, 22 CHILD ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA 493 (with M. Cohen and S. Natbony; July 2013)
Of Evergreening and Efficacy: the Glivec Patent Case, GESPAM (April 2013)
Inside Views: Potential Elements of the WHO Global R&D Treaty: Tailoring Solutions for Disparate Contexts, INTELLECTUAL PROPERTY WATCH (January 2013)
Inside Views: Access to Medicines and Intellectual Property in Jordan, INTELLECTUAL PROPERTY WATCH (July 2012)
Treating the Health Care Crisis: Complementary and Alternative Medicine for PPACA, 14 DEPAUL JOURNAL OF HEALTH CARE LAW 35 (2012)
Overcoming Barriers to a Global Treaty on Medical Funding and R&D, 7 JOURNAL OF THE BRAZILIAN INSTITUTE FOR INTELLECTUAL PROPERTY 70 (2012)
The Price of Medicines in Jordan: The Cost of Trade-Based Intellectual Property, 9 JOURNAL OF GENERIC MEDICINES 75 (with R. Bader, L. Bajjali, T. ElSamen, T. Obeidat, H. Sboul, M. Shwayat and I. Alabbadi; 2012)
Medical Student Attitudes Toward Complementary, Alternative, and Integrative Medicine, 2011 EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (with K. Hui, R. Hays, et al; 2011)
The Beijing Declaration-A Milestone for Traditional Medicine, 13 BRIDGES REVIEW (The International Centre for Trade and Sustainable Development (ICTSD); March 2009)
A Randomized Controlled Trial of Tai Chi for Tension Headaches, 4 EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 107 (with K. Hui, R. Hays, M. Li, and T. Pan; 2007)
Book Review, I. Glenn Cohen and Holly Fernandez Lynch, FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies (Columbia University Press, 2015) JOURNAL OF LAW AND THE BIOSCIENCES, 1-5 (2015)